Journal List > Investig Clin Urol > v.59(2) > 1088211

Kang, Cho, Ham, Kang, Jung, Kwon, Choi, and Lee: Predictive factors and treatment outcomes of Steinstrasse following shock wave lithotripsy for ureteral calculi: A Bayesian regression model analysis

Abstract

Purpose

This study aims to assess the predictive factors and treatment outcomes of Steinstrasse formation following shock wave lithotripsy (SWL) for ureter stone.

Materials and Methods

The medical records of 1,418 ureter stone patients who underwent one-session SWL from November 2005 to May 2013 at our medical institute were retrospectively reviewed. Finally, 551 patients met inclusion criteria. Maximal length and location of stone, stone attenuation (Hounsfield units), and skin-to-stone distance (SSD) were determined on pretreatment non-contrast computed tomography.

Results

Of 551 patients, 12 patients (2.2% of total cohort) developed Steinstrasse after one-session SWL. The Steinstrasse incidence was significantly associated with stone size, stone attenuation value, and SSD. Prophylactic ureter stenting was not a statistically significant predictor of Steinstrasse formation. After propensity-score matching, Steinstrasse group showed a significant shorter SSD compare to non-Steinstrasse group. Multivariate logistic regression and Bayesian analysis revealed that stone size, stone attenuation and SSD were significant predictor of Steinstrasse formation following SWL for ureter stone. The Steinstrasse resolved spontaneously in six patients and remaining six patients were treated by additional SWL. None of patients with Steinstrasse required ureteral stenting, percutaneous drainage, or consequent surgical intervention.

Conclusions

Steinstrasse formation following SWL for ureter stone was rare event but nonnegligible. Large stone size, high stone attenuation and short SSD were significant predictors of Steinstrasse formation following SWL for ureter stone. Majority of patients with Steinstrasse formation could be treated conservatively in this clinical scenario.

INTRODUCTION

Currently, shock wave lithotripsy (SWL) remains a widely accepted minimally invasive option for treating urinary stone disease [12]. Stones are first disintegrated by shock waves, and the fragmented stone particles are spontaneously cleared from the ureter and bladder [3]. Failed passage of stone fragments can obstruct the urinary tract, thus causing post-treatment complications such as flank pain, hydroureteronephrosis, and decreased renal function [45]. This failure can be caused by poor fragmentation efficiency so that large stone fragment obstructs the urinary tract. Alternatively, a particles of stones that are finely disintegrated can form an obstructing column of sand (Steinstrasse) in the ureter [6]. Steinstrasse formation following SWL is dependent on several factors, including stone burden, location and composition, and shockwave frequency and energy. Previous studies have shown that Steinstrasse following SWL occurs in 1%–4% of patients with small stones, 5%–10% of patients with large stone area (>2 cm2), and up to 40% of patients with partial or complete staghorn stones [7].
The increasing use of non-contrast computed tomography (NCCT) provides additional information including skin-to-stone distance (SSD) and attenuation value as mean Hounsfield units (HU) of stone [8]. Valuable information from NCCT may be a promising approach in predicting for Steinstrasse following SWL [9]. Nowadays, indications for SWL has been extended for large upper ureter calculi, thus even may cause post-SWL Steinstrasse formation [10]. Although predictive factors and clinical course of Steinstrasse following SWL for renal calculi have been described, little is known about such complication with ureter calculi. To address these issues, we investigated the predictive factors and clinical course of Steinstrasse formation following SWL for ureter stone

MATERIALS AND METHODS

Patient data were analyzed from November 2005 to May 2013 in 1,418 patients with one-session SWL at our medical institute. Patients had to fulfill the following inclusion criteria: 1) 4–20 mm sized single ureter stone; 2) radiopaque density on plain-film; 3) availability of pretreatment NCCT. Patients with multiple stones, single kidney, congenital urinary tract anomalies, or receipt of prophylactic medical expulsion therapy were excluded from analysis. Finally, 551 patients were enrolled in this retrospective study.
The detailed history and characteristics of patients with ureteral stones, including the number of history of stones, the time of onset of pain, and the characteristics of various characteristics were acquired. The characteristics of calculi included mean attenuation value (HU), SSD, location, and stone burden (maximal stone length and stone area). Attenuation value was measured by setting the bone windows in an axial NCCT scan image showing the maximum diameter of ureter stone [11]. The elliptical region was measured and the maximum area in stone was secured without containing the surrounding tissues as much as possible. The SSD was measured at 45 degrees in each vertical axis on axial image. The maximal stone length calculated by NCCT was the longest length in three dimensions including x-, y-, and z-axis of stone. We used commercially available picture archiving and communication system software for image analyses. Electroconductive lithotripter (Sonolith® Praktis; EDAP Technomed, Lyon, France) was used from 2005 to 2011 and electromagnetic generative lithotripter (Compact Delta II lithotripter; Dornier MedTech, Wessling, Germany) has been used since 2012 in our institute. A ureter stent insertion was considered prophylactically in patients with large stones (>15 mm) prior to SWL. All SWL were performed using fluoroscopic examination. The SWL was performed at 1–1.5 shock-wave per second between 2,500–4,000 shock-waves in a session with a focal peak pressure ranging from 16 to 55 MPa. When the stone identification became difficult during SWL or when the patient's degree of pain became unbearably severe, the session was terminated early. Treatment success was defined as complete clearance of the stones or presence of clinically insignificant residual fragments ≤3 mm without the need for auxiliary procedures within a 3-month follow-up period.
This study adheres to the Declaration of Helsinki and has complied with relevant laws and regulations and good clinical practice and ethical principles. Institutional Review Board of Severance Hospital approved the protocol of this study (approval number: 4-2014-1064). Because this study was a retrospective study, all participants' written informed consent was waived and all information was anonymized and preceded in a state where it could not be identified. The study quality was assessed by the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist.

Statistical analyses

Continuous variables are shown as the median and interquartile range. Differences in variables with continuous distributions were assessed using the Wilcoxon rank-sum test with continuity correction. Fisher's exact and χ2 tests were used to assess the difference between the categorical variables. Propensity score-matching with respect to patients' demographic factors and stone characteristics was employed to minimize selection bias. Non-Steinstrasse cases were 2:1 matched with the closest propensity with each Steinstrasse case [10]. Multivariate logistic regression analysis and Bayesian logistic regression model were performed to identify the predictors of Steinstrasse development following SWL for ureter stone. Detailed Bayesian statistical analysis method was described previously [1213]. All statistical analyses were performed using R software ver. 3.0.3 (R Foundation for Statistical Computing, Vienna, Austria), and the package ‘MatchIt’ and the package ‘Zelig and MCMCpack’ were used for propensity score-matching and Bayesian analysis, respectively.

RESULTS

Table 1 shows the baseline characteristics of 551 patients who underwent single-session SWL for single ureteral stones. The incidence of Steinstrasse in ureter stone patients after SWL was 2.2% (n=12). The Steinstrasse incidence was significantly associated with stone size, attenuation value, and SSD in the comparison of the Steinstrasse group and the control group based on the NCCT characteristics of patients and stones. Steinstrasse patients had significantly higher stone sizes (stone size and stone area, p=0.005 and 0.003), higher stone attenuation (p=0.004), shorter SSD (p=0.009). Prophylactic ureter stenting was not a statistically significant predictor of Steinstrasse formation (p=0.231). After non-Steinstrasse cases were 2:1 propensity-matched with each Steinstrasse case, the Steinstrasse group had a significantly shorter SSD compared to the non-Steinstrasse group (p=0.013) (Table 2).
The univariate logistic regression models for predictive factors of Steinstrasse following SWL for ureter stones revealed that stone size (odds ratio [OR], 1.160; 95% confidence interval [CI], 1.051 to 1.270; p=0.002), HU (OR, 1.003; 95% CI, 1.001 to 1.004; p=0.003), and SSD (OR, 0.968; 95% CI, 0.941 to 0.996; p=0.025) were significantly correlated with Steinstrasse formation (Table 3). In multivariate analysis, all stone NCCT parameters were independent predictors of Steinstrasse formation after SWL as a treatment for ureteral stones (Table 3). In the posterior distribution of the Bayesian logistic regression model, larger stone size (mean, 0.141; 95% CI, 0.018 to 0.253), higher HU (mean, 0.002; 95% CI, 0.001 to 0.005) and shorter SSD (mean, −0.024; 95% CI, −0.056 to −0.001) after SWL for ureter stones were important predictors of Steinstrasse development (Table 4). In Table 5, logistic regression model showed that maximal stone length and stone attenuation were significant factor for success following SWL, whereas SSD was not significant factor.
Of the 12 Steinstrasse patients, six received conservative treatment, and additional SWL was performed on the remaining six patients. In patients with repeat SWL, the average number of session of SWL was 2.83, and no serious complications occurred, such as acute pyelonephritis, urinary sepsis, or severe colic that necessitated an emergency room visit. None of Steinstrasse case needed cystoscopic ureteral stent insertion, percutaneous drainage, or consequent surgical intervention.

DISCUSSION

Present study investigated the incidence and clinical significance of Steinstrasse after SWL for single ureteral calculi. The overall incidence of Steinstrasse after SWL for single ureteral calculi was relatively rare. Computed tomography characteristics of stones were significant predictors of Steinstrasse formation. If a patient has a high probability of Steinstrasse formation following SWL for ureteral calculi, appropriate patient counseling and consideration of ureteroscopic stone surgery is indicated.
Numerous predisposing factors are involved in Steinstrasse formation, including patient characteristics (i.e., age, renal morphology, and stone history), stone traits (i.e., stone number, size, composition and location), and lithotripsy related factors (i.e., shock wave frequency and energy level) [61415]. Madbouly et al. [6] reported that stone size and location, renal morphology, and lithotripsy energy are significant predictors of Steinstrasse development. Another study by Onal et al. [16] also supported that stone burden is a significant predictor for developing Steinstrasse in pediatric urolithiasis after SWL. Our results are similar to findings of previous studies, insofar as stone burden is a significant predictor for Steinstrasse development after SWL; however, the present study has important distinctions from previous studies. The important distinction of our study was that we considered additional diverse stone characteristics elucidated by NCCT. Although CT scanning has become recognized as a useful initial evaluation tool for assessing stone disease and provides valuable stone characteristics, no report has before evaluated these stone parameters as potential predictive factors for Steinstrasse development after SWL. HU and SSD evaluated by NCCT have been suggested as potential predictors of SWL success in patients with stone disease [317]. Previous clinical studies have suggested that greater stone attenuation is associated with SWL failure, which means high-density stones requiring more shock waves for fragmentation. SSD was considered a significant factor in approximately half of published related studies [18]. Pareek et al. [19] suggested that SSD, as a manifestation of obesity, outweighed body mass index as an independent predictor of SWL success. However, in an Asian population, Choi et al. [20] reported that SSD was not a significant predictor of SWL success in both patients with small (≤10 mm) or large (>10 mm) stones. Another study by Tanaka et al. [21] also demonstrated that there was no statistical difference in SSD between groups that experienced successful and failed SWL, and SSD was not a significant predictor for success after SWL. In this study, SSD was a significant predictor of Steinstrasse development following SWL, whereas not a significant factor for SWL success. One notable characteristic of the ureter stones was that they had a longer SSD than renal stones. From a study by Wiesenthal et al. [18], mean SSDs were 98.1±24.6 mm in renal stones and 130.1±25.7 mm in ureter stones, indicating that the SSD of ureter stones was approximately 3 cm longer than that of renal stones. Thus, SSD in ureter stones cannot be a significant predictor for successful outcomes following SWL. However, in ureter stones with relatively short SSDs, the effectiveness of shock waves can be determined in the early phase of SWL. At that time, a relatively large fragmented stone may migrate into the lower ureter by peristaltic movement of ureter, which can induce inappropriate stone focusing and patient positioning in the late phase of SWL.
A Steinstrasse is commonly transient, asymptomatic, and safely treated by conservative management [16]. Steinstrasse may initially be treated conservatively, but when there is obstruction, infection, or no stone fragment progression, another treatment should be considered, including repeated SWL, percutaneous nephrostomy, endoscopic intervention, and finally open surgery [22]. In large renal stones, Steinstrasse occurs in up to 40% of patients, and percutaneous or surgical intervention is necessary. On the other hand, all of our Steinstrasse cases were successfully managed by expectancy or repeat SWL monotherapy. None of our Steinstrasse patients develop serious complications such as acute pyelonephritic attack, urinary sepsis, or severe colic that necessitated an emergency room visit. None of our Steinstrasse cases also needed decompression of the corresponding renoureteral system or consequent surgical intervention. The smaller stone burden of ureter stones may be responsible for these favorable clinical outcomes.
Our study had some inherent limitations. Its retrospective design and small sample size may have introduced sampling bias. For example, prophylactic ureteral stenting was more preferred in patients with a large stone burden. Thus, we could not confirm the influence of prophylactic stenting on Steinstrasse development after SWL for ureter stones. Moreover, two different shock-wave generating machines may be a bias, but there was no statistical difference in each period. Finally, we did not categorize patients according to Steinstrasse type and extent because most affected patients had type I and short extent (1–2 cm). Despite these limitations, we applied a Bayesian modelling approach to overcome the retrospective nature and small sample size. We are confident in our novel findings regarding the clinical utility of discrete NCCT-derived stone parameters as predictive factors of Steinstrasse development after patients undergo SWL for ureteral stones. To our knowledge, this is the first study designed to describe and evaluate Steinstrasse after SWL for ureteral calculi.

CONCLUSIONS

The incidence of Steinstrasse after SWL in ureteral stone patients was relatively rare and could be conservatively managed. Stone size, attenuation value and SSD were significant predictors of Steinstrasse development after SWL for ureter stone. Our result may provide important information that can be used to guide the treatment plan and counseling of patients with a high possibility of developing Steinstrasse after SWL for ureteral calculi.

ACKNOWLEDGMENTS

This study was supported by a faculty research grant from the Yonsei University College of Medicine for 2016 (6-2016-0119).

Notes

CONFLICTS OF INTEREST: The authors have nothing to disclose.

References

1. Perks AE, Schuler TD, Lee J, Ghiculete D, Chung DG, D'A Honey RJ, et al. Stone attenuation and skin-to-stone distance on computed tomography predicts for stone fragmentation by shock wave lithotripsy. Urology. 2008; 72:765–769. PMID: 18674803.
crossref
2. Kang DH, Cho KS, Ham WS, Chung DY, Kwon JK, Choi YD, et al. Ureteral stenting can be a negative predictor for successful outcome following shock wave lithotripsy in patients with ureteral stones. Investig Clin Urol. 2016; 57:408–416.
crossref
3. El-Nahas AR, El-Assmy AM, Mansour O, Sheir KZ. A prospective multivariate analysis of factors predicting stone disintegration by extracorporeal shock wave lithotripsy: the value of high-resolution noncontrast computed tomography. Eur Urol. 2007; 51:1688–1693. discussion 1693-4. PMID: 17161522.
crossref
4. Sulaiman MN, Buchholz NP, Clark PB. The role of ureteral stent placement in the prevention of Steinstrasse. J Endourol. 1999; 13:151–155. PMID: 10360492.
crossref
5. Chang KD, Lee JY, Park SY, Kang DH, Lee HH, Cho KS. Impact of pretreatment hydronephrosis on the success rate of shock wave lithotripsy in patients with ureteral stone. Yonsei Med J. 2017; 58:1000–1005. PMID: 28792145.
crossref
6. Madbouly K, Sheir KZ, Elsobky E, Eraky I, Kenawy M. Risk factors for the formation of a steinstrasse after extracorporeal shock wave lithotripsy: a statistical model. J Urol. 2002; 167:1239–1242. PMID: 11832705.
crossref
7. Moursy E, Gamal WM, Abuzeid A. Tamsulosin as an expulsive therapy for steinstrasse after extracorporeal shock wave lithotripsy: a randomized controlled study. Scand J Urol Nephrol. 2010; 44:315–319. PMID: 20560802.
crossref
8. Cho KS, Jung HD, Ham WS, Chung DY, Kang YJ, Jang WS, et al. Optimal skin-to-stone distance is a positive predictor for successful outcomes in upper ureter calculi following extracorporeal shock wave lithotripsy: a Bayesian model averaging approach. PLoS One. 2015; 10:e0144912. PMID: 26659086.
crossref
9. Chung DY, Cho KS, Lee DH, Han JH, Kang DH, Jung HD, et al. Impact of colic pain as a significant factor for predicting the stone free rate of one-session shock wave lithotripsy for treating ureter stones: a Bayesian logistic regression model analysis. PLoS One. 2015; 10:e0123800. PMID: 25902059.
crossref
10. Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics. 1996; 52:249–264. PMID: 8934595.
crossref
11. Lee JY, Kim JH, Kang DH, Chung DY, Lee DH, Do Jung H, et al. Stone heterogeneity index as the standard deviation of Hounsfield units: a novel predictor for shock-wave lithotripsy outcomes in ureter calculi. Sci Rep. 2016; 6:23988. PMID: 27035621.
crossref
12. Hay KE, Barnes TS, Morton JM, Clements AC, Mahony TJ. Risk factors for bovine respiratory disease in Australian feedlot cattle: use of a causal diagram-informed approach to estimate effects of animal mixing and movements before feedlot entry. Prev Vet Med. 2014; 117:160–169. PMID: 25070491.
crossref
13. Kim IK, Lee JY, Kwon JK, Park JJ, Cho KS, Ham WS, et al. Prognostic factors for urachal cancer: a bayesian model-averaging approach. Korean J Urol. 2014; 55:574–580. PMID: 25237458.
crossref
14. Fedullo LM, Pollack HM, Banner MP, Amendola MA, Van Arsdalen KN. The development of steinstrassen after ESWL: frequency, natural history, and radiologic management. AJR Am J Roentgenol. 1988; 151:1145–1147. PMID: 3263767.
crossref
15. Coptcoat MJ, Webb DR, Kellet MJ, Whitfield HN, Wickham JE. The steinstrasse: a legacy of extracorporeal lithotripsy? Eur Urol. 1988; 14:93–95. PMID: 3360043.
crossref
16. Onal B, Citgez S, Tansu N, Demirdag C, Dogan C, Gonul B, et al. Predictive factors and management of steinstrasse after shock wave lithotripsy in pediatric urolithiasis--a multivariate analysis study. Urology. 2012; 80:1127–1131. PMID: 22999455.
crossref
17. Gupta NP, Ansari MS, Kesarvani P, Kapoor A, Mukhopadhyay S. Role of computed tomography with no contrast medium enhancement in predicting the outcome of extracorporeal shock wave lithotripsy for urinary calculi. BJU Int. 2005; 95:1285–1288. PMID: 15892818.
crossref
18. Wiesenthal JD, Ghiculete D, D'A Honey RJ, Pace KT. Evaluating the importance of mean stone density and skin-to-stone distance in predicting successful shock wave lithotripsy of renal and ureteric calculi. Urol Res. 2010; 38:307–313. PMID: 20625891.
crossref
19. Pareek G, Hedican SP, Lee FT Jr, Nakada SY. Shock wave lithotripsy success determined by skin-to-stone distance on computed tomography. Urology. 2005; 66:941–944. PMID: 16286099.
crossref
20. Choi JW, Song PH, Kim HT. Predictive factors of the outcome of extracorporeal shockwave lithotripsy for ureteral stones. Korean J Urol. 2012; 53:424–430. PMID: 22741053.
crossref
21. Tanaka M, Yokota E, Toyonaga Y, Shimizu F, Ishii Y, Fujime M, et al. Stone attenuation value and cross-sectional area on computed tomography predict the success of shock wave lithotripsy. Korean J Urol. 2013; 54:454–459. PMID: 23878688.
crossref
22. Habib EI, Morsi HA, Elsheemy MS, Aboulela W, Eissa MA. Effect of size and site on the outcome of extracorporeal shock wave lithotripsy of proximal urinary stones in children. J Pediatr Urol. 2013; 9:323–327. PMID: 22695376.
crossref
Table 1

Demographic data comparisons between Steinstrasse and non-Steinstrasse groups (n=551)

icu-59-112-i001
Parameter Steinstrasse group Non-Steinstrasse group p-value
No. of patients 12 539
Age (y) 57.5 (37.0–64.0) 53.0 (42.0–62.0) 0.973a
Sex 0.320b
 Male 7 (58.3) 349 (64.7)
 Female 5 (41.7) 190 (35.3)
Maximal stone length (mm) 11.5 (9.8–15.5) 8.0 (6.0–11.0) 0.005a
Stone area (mm2) 102.5 (85.5–131.0) 54.0 (30.0–82.5) 0.003a
Stone attenuation value (Hounsfield units) 1,012 (741.1–1,141.0) 663.3 (488.9–864.8) 0.004a
Skin-to-stone distance (mm) 102.3 (91.4–106.4) 110.9 (98.4–123.6) 0.009a
No. stone episodes 1.000c
 First time stone formers 9 (75.0) 389 (72.2)
 Recurrent stone formers 3 (25.0) 150 (27.8)
Stone location 0.248b
 Upper 12 (100.0) 437 (81.1) 0.196b
 Middle 0 (0.0) 42 (7.8) 0.648b
 Lower 0 (0.0) 60 (11.1) 0.450b
Laterality 0.776c
 Right 7 (58.3) 283 (52.5)
 Left 5 (41.7) 256 (47.5)
Prophylactic ureteral stent 0.231c
 Yes 2 (16.7) 40 (7.4)
 No 10 (83.3) 499 (92.6)

Values are presented as number only, median (interquartile range), or number (%).

a:Wilcoxon rank-sum test with continuity correction, b:Pearson's chi-squared test, c:Fisher's exact test for count data.

Table 2

Demographic data between Steinstrasse and non-Steinstrasse groups from matched cohort

icu-59-112-i002
Parameter Steinstrasse group Non-Steinstrasse group p-value
No. of patients 12 24
Age (y) 57.5 (37.0–64.0) 50.50 (40.5–58.8) 0.827a
Sex 0.562b
 Male 7 (58.3) 19 (79.2)
 Female 5 (41.7) 5 (20.8)
Maximal stone length (mm) 11.5 (9.8–15.5) 12.5 (9–15.3) 0.638a
Stone area (mm2) 102.5 (85.5–131.0) 105.5 (60.0–160.0) 0.933a
Stone attenuation value (Hounsfield units) 1,012 (741.1–1,141.0) 1,036 (669.3–1,150.0) 0.986a
Skin-to-stone distance (mm) 102.3 (91.4–106.4) 114.5 (103.8–128.3) 0.013a
No. stone episodes 0.282b
 First time stone formers 9 (75.0) 12 (50.0)
 Recurrent stone formers 3 (25.0) 12 (50.0)
Stone location 0.325c
 Upper 12 (100.0) 20 (83.3) 0.278b
 Middle 0 (0.0) 2 (8.3) 0.543b
 Lower 0 (0.0) 2 (8.3) 0.543b
Laterality 0.483b
 Right 7 (58.3) 10 (41.7)
 Left 5 (41.7) 14 (58.3)
Prophylactic ureteral stent 1.000b
 Yes 2 (16.7) 5 (20.8)
 No 10 (83.3) 19 (79.2)

Values are presented as number only, median (interquartile range), or number (%).

a:Wilcoxon rank-sum test with continuity correction, b:Fisher's exact test for count data, c:Pearson's chi-squared test with Yates' continuity correction.

Table 3

Univariate and multivariate logistic regression models for predictive factors of Steinstrasse following shock wave lithotripsy for ureter stones

icu-59-112-i003
Parameter OR 95% CI p-value
Univariate
 Age 0.996 0.959–1.036 0.840
 Sex (male) 0.762 0.240–2.606 0.647
 Maximal stone length 1.160 1.051–1.270 0.002
 Stone attenuation value 1.003 1.001–1.004 0.003
 Skin-to-stone distance 0.968 0.941–0.996 0.025
 Recurrent stone formers 0.864 0.190–2.942 0.829
 Stone location
  Upper Reference
  Middle 0 0 0.992
  Lower 0 0 0.991
 Laterality (right) 1.266 0.399–4.325 0.690
 Stent 2.495 0.375–9.881 0.248
Multivariate
 Maximal stone length 1.004 1.001–1.007 0.012
 Stone attenuation value 1.000 1.000–1.001 0.027
 Skin-to-stone distance 0.988 0.987–0.999 0.047

OR, odds ratio; CI, confidence interval; HU, Hounsfield units.

Table 4

Posterior distribution for Bayesian logistic regression models for predictive factors of Steinstrasse following shock wave lithotripsy for ureter stones

icu-59-112-i004
Parameter Mean SD CI 2.5% Median CI 97.5%
Age −0.003 0.021 −0.047 −0.003 0.038
Sex (male) −0.139 0.683 −1.474 −0.153 1.209
Maximal stone length 0.141 0.060 0.018 0.142 0.253
Stone attenuation value 0.002 0.001 0.001 0.002 0.005
Skin-to-stone distance −0.024 0.016 −0.056 −0.029 −0.001

SD, standard deviation; CI, confidence interval.

Table 5

Univariate and multivariate logistic regression models for predictive factors of success rate following shock wave lithotripsy for ureter stones

icu-59-112-i005
Parameter OR 95% CI p-value
Univariate
 Age 0.992 0.980–1.005 0.223
 Sex (male) 0.812 0.554–1.183 0.282
 Maximal stone length 0.836 0.792–0.880 <0.001
 Stone attenuation value 0.997 0.996–0.998 <0.001
 Skin-to-stone distance 0.999 0.990–1.008 0.881
 Recurrent stone formers 1.006 0.677–1.508 0.976
 Stone location
  Upper Reference
  Middle 0.698 0.365–1.373 0.285
  Lower 0.772 0.444–1.372 0.367
 Laterality (right) 1.228 0.858–1.758 0.261
Multivariate
 Maximal stone length 0.974 0.964–0.983 <0.001
 Stone attenuation value 0.999 0.999–0.999 <0.001

OR, odds ratio; CI, confidence interval.

TOOLS
Similar articles